25 results for “cardiovascular biology”. Showing 25 of 39,449.
NAD(+) rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis.
Cardiovascular Molecular Biology and Regulatory Peptides, Beijing Key Laboratory of Cardiovascular
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action.
cardiovascular biology of novel GLP1-based multi-agonists currently in development
Editorial: Decoding complexity: new insights into the cellular and molecular mechanisms of cardiovascular and metabolic diseases.
Cardiovascular Biologics and Regenerative Medicine Volume 10 - 2023 | https://doi.org
Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.
cardiovascular disease: roles as biological effectors and biomarkers. Mallat Z(1), Lambeau
Cellular and molecular biology of sirtuins in cardiovascular disease.
biological function in physiological and pathological processes of the cardiovascular
The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
cardiovascular disease (CVD) risk factors only. Therefore, this study aimed to investigate and compare the characteristics of patients starting dialysis in a homogeneous Alpin region and possibly to identify
Network of biomarkers and their mediation effects on the associations between regular exercise and the incidence of cardiovascular & metabolic diseases.
biological process related to the prevention of cardiovascular & metabolic diseases
Autophagy and cardiovascular aging: lesson learned from rapamycin.
biological aging process is commonly associated with increased risk of cardiovascular
Immunological biomarkers of aging.
biological aging processes, such as cancer, cardiovascular disease, neurodegeneration, and frailty
An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells.
biology in yeast to human neurodegenerative, inflammatory, cardiovascular and neoplastic
Lipoprotein receptor signalling in atherosclerosis.
cardiovascular disease risks in humans. Further knowledge of the vascular biology
Obesity accelerates cardiovascular ageing.
cardiovascular system. By comparatively analysing their characteristic features, shared molecular and cell biological
Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.
Biology, University of Oklahoma Health Sciences Center (M.L.B.). (3)Atherosclerosis Research Unit, Cardiovascular
Differences in epigenetic age acceleration according to a diagnosis of endometriosis/adenomyosis: the Norwegian Mother, Father and Child Cohort Study.
cardiovascular disease and cancer. Whether this reflects differences in biological
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective.
cardiovascular diseases, neurodegeneration, cancer, etc. In turn, patients suffering from these diseases are biologically
Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.
Cardiovascular Disease Center, Washington University School of Medicine, St. Louis, MO 63110, USA. (4)Department of Developmental Biology
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans.
biological processes, including cortical excitability, stress response, food intake, circadian rhythms, and cardiovascular
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human.
biology to cardiac dysfunction in pregnancy and help to elucidate the pathogenesis underlying cardiovascular
Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.
biological data of non-steroidal LXR modulators claimed for the treatment of cardiovascular
Tumour extracellular vesicles and particles induce liver metabolic dysfunction.
Biology in Medical Sciences, Hangzhou, China. (6)Duke Proteomics and Metabolomics Shared Resource, Duke University School of Medicine, Durham, NC, USA. (7)Cardiovascular
New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms.
biologic processes through multiple pathways. Other than that, the JAK2 V617F mutation affects the cardiovascular
Leukaemia: Crowd control.
biological subgroups, and indefinite covalent Bruton tyrosine kinase inhibitor (cBTKI) is associated with cumulative cardiovascular
Klotho, Kidneys, and Micronutrient Signaling: A Promising Paradigm for Healthy Aging.
biological and chronological aging and has been mechanistically implicated in the pathogenesis of chronic kidney disease, cardiovascular
Lithocholic Acid, Calorie Restriction, and Halting Aging.
biological process, it is associated with a greater risk for multiple diseases, including cancer, neurodegeneration, and cardiovascular
Concept and connotation of the geroprotective and anti-aging effects of metformin: From AMPK Activation to SASP Suppression.
Biological aging is the risk factor underlying most of the chronic diseases of late life, such as cardiovascular